Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis

Summary

efficacy study in patients with moderate to severe plaque psoriasis.

Timeline

Start

2010-08

Primary completion

2010-12

Completion

2011-01

Outcome

Met primary endpoint

registry Desoximetasone Spray 0.25% vs Placebo; p = 0.0003; t-test, 2 sided NCT01206387 ↗

registry Desoximetasone Spray 0.25% vs Placebo; p <0.0001; t-test, 2 sided NCT01206387 ↗

Publications

• Saleem MD, Negus D, Feldman SR. Topical 0.25% desoximetasone spray efficacy for moderate to severe plaque psoriasis: a randomized clinical trial. J Dermatolog Treat. 2018 Feb;29(1):32-35. doi: 10.1080/09546634.2017.1331027. Epub 2017 May 30.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Desoximetasone	Small molecule	0.25 %	Topical

Indications